Xylo Technologies (STU:2QM0) Total Equity : €29.74 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Xylo Technologies Total Equity?

Xylo Technologies's total equity for the quarter that ended in Dec. 2023 was €29.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Xylo Technologies Total Equity Historical Data

The historical data trend for Xylo Technologies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Total Equity Chart

Xylo Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

7.32

21.53

45.52

51.63

29.74

Xylo Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Equity	Get a 7-Day Free Trial															45.52	50.32	51.63	41.03	29.74

Xylo Technologies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Xylo Technologies's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	58.593	-	28.85
	=	29.74

Xylo Technologies's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	58.593	-	28.85
	=	29.74

Xylo Technologies Total Equity Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Xylo Technologies (STU:2QM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (STU:2QM0) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

MDGS:USA 2QM0:Germany

Address

10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072

Website

https://www.medigus.com

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Xylo Technologies (STU:2QM0) Headlines

No Headlines